Presentation TCT 2017 FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, William F. Fearon November 02, 2017
Presentation TCT 2017 ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Rasha Al-Lamee November 02, 2017
Presentation TCT 2017 ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone November 01, 2017
Presentation TCT 2017 Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples) Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn November 01, 2017
Presentation TCT 2017 Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein November 01, 2017
Presentation TCT 2017 REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata November 01, 2017
Presentation TCT 2017 DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi November 01, 2017
Presentation TCT 2017 SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne November 01, 2017
Presentation TCT 2017 Supersaturated Oxygen for Large Anterior STEMI: Results of the IC-HOT Approval Study Presenter: Bernard J. Gersh, Michel Ovize, Gregg W. Stone October 31, 2017
Presentation TCT 2017 Inter-atrial Shunts I: V-Wave Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Gregg W. Stone October 31, 2017
Presentation TCT 2017 The Role of Left Main PCI After EXCEL and NOBLE Presenter: Alaide Chieffo, Jonathan M. Hill, Gregg W. Stone October 31, 2017
Presentation TCT 2017 WaveCrest: Device Description, Data, and Future Directions Presenter: Mark Reisman, Josep Rodés-Cabau, Gregg W. Stone October 31, 2017
Presentation TCT 2017 What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis Presenter: Azeem Latib, Gregg W. Stone October 31, 2017
Presentation TCT 2017 Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold Presenter: Azeem Latib, Gregg W. Stone October 31, 2017
Presentation TCT 2017 EXCEL Trial 3-Year Results Updated and New Data Presenter: Antonio Colombo, David E. Kandzari, Gregg W. Stone October 31, 2017
Presentation TCT 2017 Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB PSP: Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation Presenter: Y. S. Chandrashekhar, David J. Moliterno, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Gregg W. Stone October 31, 2017
Presentation TCT 2017 Anticipating CoAPT: Two Year Roll-in Results and RCT Progress Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Gregg W. Stone October 30, 2017
Presentation TCT 2017 Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017